SERA: Sera Prognostics, Inc. Stock

by  •  • Comments Off on SERA: Sera Prognostics, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 381.57
Enterprise Value ($M) 377.69
Book Value ($M) 70.16
Book Value / Share 2.15
Price / Book 5.44
NCAV ($M) 36.06
NCAV / Share 1.10
Price / NCAV 10.58

Profitability (mra)
Return on Invested Capital (ROIC) -0.50
Return on Assets (ROA) -0.34
Return on Equity (ROE) -0.40

Liquidity (mrq)
Quick Ratio 2.51
Current Ratio 2.51

Balance Sheet (mrq) ($M)
Current Assets 61.34
Assets 95.44
Liabilities 25.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.31
Operating Income -39.82
Net Income -36.24

Cash Flow Statement (mra) ($M)
Cash From Operations -27.19
Cash from Investing 0.44
Cash from Financing 0.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-01 13G Ra Capital Management, L.p. 6.50
02-13 13G/A Vivo Capital IX, LLC 5.40 -11.08
01-26 13G/A Domain Partners VIII, L.P. 4.30 -47.52
01-19 13G/A Interwest Partners X Lp 0.40 -95.03
01-10 13G Baker Bros. Advisors Lp 17.90
01-03 13G/A Schindel Yair Chaim 9.50 55.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 23,129 151,360 15.28
2024-04-30 21,217 28,606 74.17
2024-04-29 13,195 25,518 51.71
2024-04-26 9,131 20,806 43.89

(click for more detail)

Similar Companies
FLGT – Fulgent Genetics, Inc. PSNL – Personalis, Inc.
RDNT – RadNet, Inc. VCYT – Veracyte, Inc.


Financial data and stock pages provided by
Fintel.io